he purpose of this report was to update the 2006 International League Against Epilepsy (ILAE) report and identify the level of evidence for long-term efficacy or effectiveness for antiepileptic drugs (AEDs) as initial monotherapy for patients with newly diagnosed or untreated epilepsy. All applicable articles from July 2005 until March 2012 were identified, evaluated, and combined with the previous ysis (Glauser et al., 2006) to provide a comprehensive update.
The prior ysis methodology was utilized with three modifications: (1) the detectable noninferiority boundary approach was dropped and both failed superiority studies and prespecified noninferiority studies were yzed using a noninferiority approach, (2) the definition of an adequate comparator was clarified and now includes an absolute minimum point estimate for efficacy/effectiveness, and (3) the relationship table between clinical trial ratings, level of evidence, and conclusions no longer includes a recommendation column to reinforce that this review of efficacy/evidence for specific seizure types does not imply treatment recommendations.
This evidence review contains one clarification: The commission has determined that class I superiority studies can be designed to detect up to a 20% absolute (rather than relative) difference in the point estimate of efficacy/effectiveness between study treatment and comparator using an intent-to-treat ysis. Since July, 2005, three class I randomized controlled trials (RCT) and 11 class III RCTs he been published. The combined ysis (1940-2012) now includes a total of 64 RCTs (7 with class I evidence, 2 with class II evidence) and 11 meta-yses.
New efficacy/effectiveness findings include the following: levetiracetam and zonisamide he level A evidence in s with partial onset seizures and both ethosuximide and valproic acid he level A evidence in children with childhood absence epilepsy.
There are no major changes in the level of evidence for any other subgroup. Levetiracetam and zonisamide join carbamazepine and phenytoin with level A efficacy/effectiveness evidence as initial monotherapy for s with partial onset seizures. Although ethosuximide and valproic acid now he level A efficacy/effectiveness evidence as initial monotherapy for children with absence seizures, there continues to be an alarming lack of well designed, properly conducted epilepsy RCTs for patients with generalized seizures/epilepsies and in children in general.
These findings reinforce the need for multicenter, multinational efforts to design, conduct, and yze future clinically relevant adequately designed RCTs. When selecting a patient's AED, all relevant variables and not just efficacy and effectiveness should be considered.
查看信源地址
上一页:小儿癫痫病症的早期症状是什么
下一页:成年人痉挛的主要病因有哪些
- 2022-05-05樟脑丸成分 医学应该谨防伤身
- 2022-04-28小孩发烧怎么止痛药 孩子发烧有妙招(8)
- 2022-04-26少年儿童癫痫病因是什么呢
- 2022-04-212013年国际抗癫痫总会抗癫痫药使用指南
- 2022-04-04私密┃月经结束了。内衣上这些棕色的东西是什么?
- Clin Pharmacol Ther:有针对性地使用安慰剂可有效减少特应性皮炎患者的瘙痒
- Eur Radiol:MR胰腺导管内粘液性恶性可能性的纹理分析!
- 溢液是怎么回事?
- 17 年度经验:随访胡须斑秃预后
- 智能手机真能成为诊断工具吗?未必!
- 银屑病常用药物进入医疗保险,有效减轻患者的医疗负担
- 钙化是一种疾病吗?你想治疗吗?读完这篇文章后,你可以放心吗?
- 私密┃月经结束了。内衣上这些棕色的东西是什么?
- 肝脏占位难以诊断
- JAMA Surg:破裂是影响局限性胃肠间质瘤患者术后生存的重要因素
- BMJ:妊娠长短与子宫内膜癌风险
- 乳腺增生结节疏通茶 | 改善月经前胀痛
- 哪些习惯容易伤害我们的子宫?
- 女生痛经只会多喝热水?快速学习这些救命的方法!
- 断奶并不可怕,更不用说紧张了,应该这样做
- 如何预防附件炎高发?做好这五点预防!女孩子应该知道
- 【预约直播】铿锵的论道 不炎,越来越多--「郁金香论坛」学术沙龙即将举行
- 阻碍性福的隐形杀手
- 互联网医疗和医生如何依靠服务而不开药?
- 2018 KSOG立场声明:双侧输卵管切除术降低女性卵巢癌/输卵管癌/腹膜癌的平均风险
- 妇科解剖记忆公式有点长,非常详细!
- 中国还是成立新的疾控机构?大疾控局呼之欲出
- 难言之隐困扰了她40年,手术3小时让她一身轻松
- 白癜风早期症状
- 如何制作健康的元宵节
- 癫痫患者如何克服忘记吃药的问题?
- 注意┃要好好照顾,不仅可以避免妇科疾病,还有助于怀孕!
- 术前如何准备会阴穿刺活检?
- 成年人痉挛有哪些病因
- 癫痫的症状 睡中犯癫痫会有哪些表现
- 神经胶质瘤一定要治疗吗?术后并发症有哪些?
- 怎么治疗癫痫病有不断更新方法吗
- 中医如何治疗癫痫病 癫痫病的卫生保健
- 治疗癫痫病的最佳方法有如何能治好
- 妇女癫痫预防的这两项
- 癫痫的放射治疗方法 中医拔罐治癫痫小方法(2)
- 癫痫动手术治疗危险大吗?专家解读:选择动手术治疗必须了解这些事
- 昭和年间好癫痫病比较好的方法是什么
- 罗氏制药发布致医师信警示甲氟喹的神经精神不良反应
- 引起抑郁症的病因是什么